Blood Test Spots Alzheimer’s Years Ahead

A new study shows that a simple blood test can flag the risk of Alzheimer’s long before any brain scan or symptoms appear. The test measures a specific form of tau protein called pTau217 in the blood, which has been linked to the toxic tangles that form inside Alzheimer’s brains. Researchers followed 317 adults, aged 50 to 90, over eight years. They collected blood samples and performed PET scans that look for amyloid plaques or tau tangles, while also testing memory and thinking skills. The results revealed that people with higher pTau217 levels had a quicker rise in amyloid plaques and tau tangles, even when their initial scans looked normal. In many cases, the blood marker rose before any plaque could be seen on a scan. Conversely, those with low pTau217 rarely developed plaques or tangles in later scans.This suggests that the blood test could identify individuals who will become amyloid‑positive before brain scans do. Early detection is crucial because current Alzheimer’s drugs work best when started early, before significant brain damage has occurred. The researchers caution that more studies are needed before the test can become a routine screening tool for older adults. However, it could be useful in clinical trials to pick participants at higher risk of developing Alzheimer’s, speeding up the search for new treatments. If future research confirms these findings, doctors might use this blood test to monitor at‑risk patients and intervene sooner, potentially slowing the progression of the disease.